Skip to content

Hims & Hers Health

US · HIMS #1813 by market cap Listed 1970
14.60 -1.42 -8.86%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 15.79 -1.44%
After-hours 15.13 +3.63%
Overnight 15.87 -0.94%
38.2814.6014.602026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on HIMS?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -55.4% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has fallen to 22.1% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days D → E

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2849 U.S. stocks StockVane covers.

Last computed: 2026-11-21 08:27 UTC

Data coverage: 4 of 6 factors. Missing data is not a zero score.

Overall D+

The radar needs all six factors. Available grades are shown below.

Valuation N/A

How expensive the stock is versus earnings, sales and its own 5-year history.

Not enough data to grade this factor.

Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability B+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 73.8% Better than 86%
Operating margin 4.5% Better than 33%
Net margin 5.5% Better than 45%
Return on equity 25.2% Better than 84%
Return on invested capital 11.9% Better than 75%
Momentum D-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -56.8% Better than 3%
6-month return -38.5% Better than 13%
12-month return (ex latest month) -16.1% Better than 17%
Distance below 52-week high 64.4% Better than 8%
Financial Health D-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.9x Better than 53%
Debt to assets 52.0% Better than 14%
Interest coverage -194.1x Better than 4%
Free cash flow / net income 44.7% Better than 12%
Analyst View B-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 25.0% Better than 11%
Upside to average target 100.1% Better than 83%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -26.00%
1M -50.02%
3M -54.17%
6M -36.63%
YTD -55.04%
1Y -56.57%
3Y +88.63%
5Y +99.73%

Key statistics

Price & volume

Prev close
16.02
Open
15.51
Day range
14.51 - 15.96
Avg price
15.04
Volume
16.13M
Turnover
242.53M
Amplitude
9.07%
52-week range
13.74 - 40.99

Valuation

P/E
28.63
P/E (TTM)
-17.59
P/B
9.63
EPS
0.51
Net profit
119.55M
Net assets
355.37M

Share structure

Market cap
3.42B
Float cap
3.13B
Shares out
234.41M
Float shares
214.56M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 3% of range
13.74 40.99

64.4% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+21.46M net over the window

Short interest

Shares short
51.66M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Hims & Hers Health (HIMS)?

Hims & Hers Health last traded at 14.60. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Hims & Hers Health's market cap?

About 3.42B.

What is the P/E ratio of Hims & Hers Health?

The trailing twelve-month P/E is -17.59. The Valuation tab shows it against the stock's own five-year range.

Does Hims & Hers Health pay a dividend?

Hims & Hers Health does not currently pay a regular dividend.

Is Hims & Hers Health a buy according to analysts?

The consensus of 12 analysts is a Buy rating, with an average 12-month price target of 29.22, which implies 100.1% upside from the current price. This is not investment advice.

What is Hims & Hers Health's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Hims & Hers Health a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.

Quote time 2026-11-20 20:02:17 · For reference only, not investment advice and not tailored to your situation.

Hims & Hers Health discussion 0 comments

Add a comment